AI Diagnostic Platform Company Noul Enters Cancer Diagnostic Business with the Launch of Cervical Cell Analysis Product

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Noul-Cancer-Business

More Like This

PR Newswire associated0

On-Device AI Healthcare Company Noul Becomes First Korean Diagnostic Company to Join Swiss Malaria Group

PR Newswire associated0

Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs

PR Newswire associated0

Noul and Limbach Gruppe, Germany's top lab chain, to sign an agreement for the supply of miLab™ BCM

PR Newswire associated0

/C O R R E C T I O N -- Menarini Silicon Biosystems/

PR Newswire associated0

Ozelle Launches Next-Generation AI + Complete Blood Morphology Solution at MEDICA 2025

Business Wire logo

Diagnostics.ai Launches Industry's First CE-IVDR Certified Transparent AI Platform for Molecular Diagnostics as Regulatory Deadlines take Effect

PR Newswire associated0

From Morphology to Clinical Insights: Ozelle's AI-Powered Diagnostics at WHX Labs Dubai 2026

Business Wire logo

Owkin Announces International Validation Results of BRCAura: AI-Driven Screening for gBRCA Mutations Directly From Pathology Slides